查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球β-聚葡萄糖市场：按类别、按原料、按应用、按类型、按地区 - 预测（截至 2029 年）
市场调查报告书
商品编码
1473658

全球β-聚葡萄糖市场：按类别、按原料、按应用、按类型、按地区 - 预测（截至 2029 年）

Beta-Glucan Market by Category (Soluble, Insoluble), Source (Cereal & Grains, Mushroom, Yeast, Seaweed), Application (Food & Beverage, Dietary Supplement, Personal Care, Cosmetics, Pharmaceutical, Animal Feed), Type and Region - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 323 Pages | 订单完成后即时交付

价格
简介目录

全球β-聚葡萄糖市场规模预计将从2024年的5.42亿美元成长到2029年的8亿美元，预测期间内复合年增长率为8.1%。

有几个因素正在推动市场的成长，包括消费者对食品和饮料中天然和洁净标示添加剂的偏好不断增加。随着人们健康意识的增强，对天然健康产品的需求不断增长。 β-聚葡萄糖是一种水溶性膳食纤维，存在于燕麦、大麦和蘑菇等多种食物中，恰好符合这一趋势。除了作为天然添加剂外，它还具有功能优势，使其成为广泛用于食品和饮料产品的有吸引力的材料。

调查范围
调查年份 2024-2029
基准年 2023年
预测期 2024-2029
考虑单位 金额（美元）/数量（吨）
按细分市场 原料/用途/类别/类型/提取分类（定性）/地区
目标区域 北美、欧洲、亚太、南美等地区

消费者对高纤维饮食的认识和采用越来越多。众所周知，高纤维饮食可以带来多种健康益处，包括改善消化器官系统健康、改善体重管理以及降低心臟病和糖尿病等慢性疾病的风险。 β-聚葡萄糖是一种可溶性膳食纤维，已被证明可以降低胆固醇水平并改善心臟健康，使其成为注重健康的消费者的热门成分。

预计到 2024 年，粮食产业将占据最大份额：

众所周知，谷物比许多其他食品含有更高水平的 β-聚葡萄糖。燕麦和大麦富含β-聚葡萄糖，使燕麦成为最丰富的食物来源之一。谷类中发现的β-聚葡萄糖通常是混合键结的，具有有益的健康作用，包括免疫调节和降低胆固醇的作用。由于β-聚葡萄糖含量高，谷物已成为这种有益化合物的来源。 Beneo 最近在 2023 年 7 月推出了 Orafti B-Fit（一种大麦 β-聚葡萄糖来源），体现了业界对 β-聚葡萄糖及其健康益处的认识不断增强的反应。这种创新产品不仅具有显着的健康益处，包括改善心臟健康和血糖值管理，而且还为食品製造商提供了一种有吸引力的成分来生产营养产品。 Beneo 推出的 Orafti B-Fit 是更广泛趋势的一部分，在这一趋势中，该公司透过开发和推出新产品来积极响应对 β-聚葡萄糖不断增长的需求。诸如此类的倡议表明了该行业致力于将营养与健康联繫起来并满足消费者对功能性、促进健康的食品的需求。

按类别划分，水溶性 β聚葡萄糖细分市场预计将在预测期内主导市场：

可溶性β-聚葡萄糖是一种可溶性膳食纤维，存在于燕麦、大麦和洋菇等食品中，具有多种健康益处。这些包括降低胆固醇、增强免疫反应以及降低某些癌症的可能性。

随着研究结果不断发表并强调其促进健康的作用，人们对水溶性 β-聚葡萄糖的兴趣与日俱增。 《营养》杂誌上发表的 2020 年研究发现，将燕麦和大麦中的 β-聚葡萄糖纳入饮食中可以降低总胆固醇和低密度脂蛋白胆固醇，这是马苏心臟病风险的关键指标。此外，该研究还提出了与心血管系统相关的其他益处，例如β-聚葡萄糖抑制发炎和增强内皮功能。

北美地区由于饮食习惯的变化而占据市场主导地位：

由于β-葡聚醣在各种产品中的多方面应用以及相关的健康益处，北美β-聚葡萄糖市场正在经历强劲成长。嘉吉（美国）、密理博西格玛（德国）和乐斯福（法国）等主要企业正在探索β-聚葡萄糖在食品和饮料行业中作为增稠剂、脂肪替代品、膳食纤维、降胆固醇剂等的用途。这些进步预计将推动该地区的市场成长。

该报告调查了全球β-聚葡萄糖市场，并提供了市场概况、市场影响因素和市场机会分析、技术和专利趋势、法律制度、市场规模趋势和预测，以及各个细分市场和地区的主要企业资料。

目录

第一章 简介

第二章调查方法

第三章执行摘要

第 4 章重要考察

第五章市场概况

  • 总体经济指标
    • 全球国内生产总值和人口成长将增加对β-聚葡萄糖的需求
    • 日益严重的健康问题和不断上升的疾病发生率
    • 增加膳食纤维摄取量
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
    • 任务

第六章 产业趋势

  • 供应链分析
  • 价值链分析
  • 贸易分析
  • 技术分析
  • 价格分析
  • 生态系/市场地图
  • 影响客户业务的趋势/干扰
  • 专利分析
  • 主要会议及活动
  • 监管状况
  • 波特五力分析
  • 主要相关利益者和采购标准
  • 案例研究分析
  • β-聚葡萄糖纯度分析

第七章 β-聚葡萄糖市场：依萃取类别

  • 谷物衍生的 β聚葡萄糖
  • 酵母衍生的 β聚葡萄糖

第 8 章 β聚葡萄糖市场：依应用分类

  • 食品与饮品
  • 个人护理
  • 化妆品
  • 药品
  • 营养补充食品
  • 动物饲料

第 9 章 β-聚葡萄糖市场：依品牌

  • EPICOR
  • BETAVIA
  • M-GARD
  • AVENACARE
  • AB BIOTEK HUMAN NUTRITION AND HEALTH
  • YESTIMUN
  • BENICAROS
  • IMMUDYNE NUTRITIONAL PUREMUNE
  • WELLMUNE
  • 其他的
    • OATWELL
    • PROMOAT
    • SANACEL
    • AVENACARE
    • NUTRIM

第 10 章 β-聚葡萄糖市场：依类别

  • 水溶性β聚葡萄糖
  • 不溶性β聚葡萄糖

第十一章 β-聚葡萄糖市场：依原料分类

  • 粮食
  • 菇
  • 酵母菌
  • 海藻

第十二章 β-聚葡萄糖市场：依类型

  • 1,3β-聚葡萄糖
  • 1,4β-聚葡萄糖
  • 1,6β-聚葡萄糖

第十三章 β-聚葡萄糖市场：依地区

  • 北美洲
  • 欧洲
  • 亚太地区
  • 南美洲
  • 其他地区

第14章竞争格局

  • 概述
  • 收益分析
  • 市场占有率分析
  • 主要企业/主要企业策略
  • 企业价值评估及财务指标
  • 品牌/产品比较分析
  • 企业评价矩阵：主要企业
  • 公司评估矩阵：Start-Ups/中小企业
  • 竞争格局及趋势

第十五章 公司简介

  • 主要企业
    • TATE & LYLE PLC
    • KERRY GROUP PLC
    • DSM-FIRMENICH
    • ANGEL YEAST CO., LTD.
    • MERCK
    • ASSOCIATED BRITISH FOODS PLC
    • CEAPRO INC.
    • LESAFFRE
    • KEMIN INDUSTRIES, INC.
    • FOODCHEM INTERNATIONAL CORPORATION
    • LALLEMAND
    • BIORIGIN
    • NUTRISCIENCE INNOVATIONS, LLC
    • LEIBER
    • GARUDA INTERNATIONAL INC.
  • 其他公司
    • VW-INGREDIENTS
    • SUPER BETA GLUCAN
    • GLYCANOVA AS
    • SPECIALTY BIOTECH CO., LTD.
    • ALGALIF ICELAND HF.
    • NATURAL BIOLOGICS
    • ABAC R&D AG
    • BENEO
    • L&P FOOD INGREDIENT CO., LTD
    • BETA BIO TECHNOLOGY SP. Z OO
  • 基于产品的公司
    • CARGILL, INCORPORATED
    • INTERNATIONAL FLAVORS & FRAGRANCES, INC.
    • VIVESA HOLDING SRO
    • ALERIS
    • ICC
    • PROSOL SPA
    • ABN APLICACIONES BIOLOGICAS A LA NUTRICION
    • EW NUTRITION
    • BIOCHEM ZUSATZSTOFFE HANDELS-UND PRODUKTIONSGESELLSCHAFT MBH
    • MIBELLE BIOCHEMISTRY

第十六章邻近市场/相关市场

第十七章附录

简介目录
Product Code: FB 5113

The beta-glucan market is on a trajectory to witness substantial growth, with its value expected to soar from USD 542 million in 2024 to an estimated USD 800 million by 2029. This expansion represents a healthy CAGR of 8.1% throughout the projected period. Several key factors are fueling this upward trend, there is a growing consumer preference for natural and clean-label additives in food and beverages. As people become more health-conscious, there's an increasing demand for products that are perceived as natural and wholesome. Beta-glucan, which is a soluble fiber found in various sources such as oats, barley, and mushrooms, fits into this trend perfectly. It not only acts as a natural additive but also offers functional benefits, making it attractive for use in a wide range of food and beverage products.

Scope of the Report
Years Considered for the Study2024-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD), Volume (Ton)
SegmentsBy Source, by Application, by Category, by Type, by Extraction method (Qualitative) And Region
Regions coveredNorth America, Europe, Asia Pacific, South America, and RoW

There is a rising awareness and adoption of high-fiber diets among consumers. High-fiber diets are known to offer a myriad of health benefits, including improved digestive health, better weight management, and reduced risk of chronic diseases like heart disease and diabetes. Beta-glucan, being a soluble fiber, has been shown to help lower cholesterol levels and improve heart health, making it a sought-after ingredient for health-conscious consumers.

"The segment cereals & grains is expected to account for the largest share in 2024."

Cereals and grains are recognized for their elevated levels of beta-glucan compared to many other food types. Notably, oats and barley are particularly rich in beta-glucan, with oats standing out as one of the most abundant dietary sources. The beta-glucans found in cereals and grains are usually of the mixed-linkage variety, which has demonstrated beneficial health effects, including immune-modulating and cholesterol-reducing properties. Due to their high beta-glucan content, cereals and grains are sought-after sources for obtaining this advantageous compound. Beneo's recent launch of Orafti B-Fit in July 2023, a barley beta-glucans ingredient, exemplifies the industry's response to increasing awareness of beta-glucans and their health benefits. This innovative product not only offers significant health advantages like improving heart health and blood sugar management but also provides food manufacturers with an appealing ingredient for creating nutritional products. Beneo's introduction of Orafti B-Fit is part of a broader trend where companies are actively meeting the rising demand for beta-glucans by developing and launching new products. Such initiatives demonstrate the industry's commitment to connecting nutrition and health, addressing consumer needs for functional and health-promoting food options.

"The soluble beta-glucan segment is projected to dominate the market in the category segment during the forecast period."

Soluble beta-glucan, a form of soluble fiber present in foods like oats, barley, and mushrooms, offers a range of health advantages. These include lowering cholesterol, enhancing immune response, and potentially decreasing the likelihood of certain cancers.

The surging interest in soluble beta-glucan is fueled by an expanding body of research highlighting its health-promoting properties. A 2020 study featured in Nutrients found that incorporating beta-glucan from sources like oats and barley into one's diet can lead to reductions in both total and LDL cholesterol, key indicators of heart disease risk. Furthermore, the study suggested additional cardiovascular benefits associated with beta-glucan, such as diminishing inflammation and boosting endothelial function..

"Changes in dietary choices have positioned North America as a dominating region in the beta-glucan market."

The North American beta-glucan market is experiencing robust growth, driven by its multifaceted applications across various products and the associated health benefits. Leading market players, including Cargill (US), Millipore Sigma (Germany), and Lesaffre (France), are leveraging technological innovations to expand beta-glucan's use in the food and beverage industry, serving as thickening agents, fat substitutes, dietary fiber, and hypocholesterolemic agents. These advancements are anticipated to fuel market growth in the region.

In the US, consumer trends are shifting towards calorie-conscious choices, leading to a preference for low-calorie and low-fat food options. This change is not only influenced by a general health consciousness but also by the rising prevalence of obesity and cardiovascular diseases. Data from the CDC and the National Health and Nutrition Examination Survey (2021-2022) indicates that the obesity rate among adults in the US has surged to 42.4% between 2020 and 2021.

Furthermore, the escalating number of diabetes cases is reshaping dietary habits, with consumers increasingly seeking natural and low-calorie ingredients to manage their health. Given the significant diabetes prevalence in the US, where 38.4 million people, or 11.6% of the population, have diabetes and an additional 97.6 million adults have prediabetes, there is a growing demand for functional food ingredients like beta-glucan. Beta-glucan's potential benefits in managing blood sugar levels make it a particularly attractive option for diabetes patients and those at risk of developing the condition. As such, the changing dietary habits driven by the diabetes epidemic are expected to further propel the growth of the beta-glucan market in North America.

The break-up of the profile of primary participants in the beta-glucan market:

  • By Company Type: Tier 1 - 25%, Tier 2 - 45%, and Tier 3 - 30%
  • By Designation: CXO's - 20%, Managers - 50%, Executives- 30%
  • By Region: North America - 25%, Europe - 20%, Asia Pacific - 30%, South America - 15% and Rest of the World -10%

Prominent companies Tate & Lyle PLC (London), Kerry Group PLC (Ireland), DSM Firmenich (Switzerland), Merck (US), Kemin Industries (US), Alltech (US), AngelYeast Co., Ltd (China), Lallemand Inc. (Canada), Leiber (Germany), Lesaffre (France) Associated British Foods Plc (UK), Biorigin (Brazil), Ceapro Inc. (Canada), Specialty Biotech Co., Ltd. (US), Alltech (US), Garuda International Inc. (US), and Leiber (Germany).

Other players include VW-Ingredients (Netherlands), Super Beta Glucan(US), GlycaNova AS (Norway), NutriScience Innovations, LLC (US), Algalif Iceland hf. (Iceland), ABAC R&D (Switzerland), Natural Biologics (New Zealand), BENEO (Germany), L&P Food Ingredient Co., Ltd. (China), Beta Bio Technology sp. z o. o (Poland).

Research Coverage:

This research report categorizes the beta-glucan market by Source (Grains & Cereals, Mushrooms, Yeast, and Seaweed), Category (Soluble and Insoluble), Application (Food & Beverage, Personal Care, Pharmaceutical, Dietary Supplement and Animal Feed), Type ( {1,3} beta-glucan, {1,4} beta-glucan, {1,6} beta-glucan) and region (North America, Europe, Asia Pacific, South America, and Rest of the World). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the beta-glucan market. A detailed analysis of the key industry players has been done to provide insights into their business overview, key strategies, contracts, partnerships & agreements, new product launches, mergers & acquisitions, and recent developments associated with the beta-glucan market. Competitive analysis of upcoming startups in the de-oiled lecithin market ecosystem is covered in this report.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall beta-glucan market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

  • Analysis of key drivers (Increase in application of beta glucan in different industries), restraints (Inconsistency in regulatory norms governing beta-glucan), opportunities (Untapped beta-glucan applications), and challenges (Lack of consumer awareness) influencing the growth of the beta-glucan market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the beta-glucan market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the beta-glucan market across varied regions.
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the beta-glucan market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Tate & Lyle PLC (England), Kerry Group PLC (Ireland), dsm-Firmenich (Switzerland), Merck (Germany), among others in the beta-glucan market strategies. The report also helps stakeholders understand the beta-glucan market and provides them information on key market drivers, restraints, challenges, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKET SEGMENTATION
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 REGIONS COVERED
    • 1.3.4 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
    • TABLE 1 USD EXCHANGE RATES, 2019-2023
  • 1.5 UNIT CONSIDERED
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES
    • 1.7.1 IMPACT OF RECESSION

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 BETA-GLUCAN MARKET: RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Breakdown of primary profiles
    • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
      • 2.1.2.3 Key insights from industry experts
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 TOP-DOWN APPROACH
    • FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
    • 2.2.2 SUPPLY-SIDE ANALYSIS
    • FIGURE 4 BETA-GLUCAN MARKET SIZE CALCULATION: SUPPLY SIDE
    • 2.2.3 BOTTOM-UP APPROACH (DEMAND SIDE)
    • FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • 2.3 DATA TRIANGULATION AND MARKET BREAKUP
    • FIGURE 6 DATA TRIANGULATION
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 LIMITATIONS AND RISK ASSESSMENT
  • 2.6 RECESSION IMPACT ANALYSIS
    • 2.6.1 MACRO-INDICATORS OF RECESSION
    • FIGURE 7 RECESSION INDICATORS
    • FIGURE 8 GLOBAL INFLATION RATE, 2011-2022
    • FIGURE 9 GLOBAL GDP, 2011-2022 (USD TRILLION)
    • FIGURE 10 RECESSION INDICATORS AND THEIR IMPACT ON BETA-GLUCAN MARKET
    • FIGURE 11 GLOBAL BETA-GLUCAN MARKET: EARLIER FORECAST VS. RECESSION FORECAST

3 EXECUTIVE SUMMARY

    • TABLE 2 BETA-GLUCAN MARKET SHARE SNAPSHOT, 2024 VS. 2029 (USD MILLION)
    • FIGURE 12 BETA-GLUCAN MARKET, BY SOURCE, 2024 VS. 2029 (USD MILLION)
    • FIGURE 13 BETA-GLUCAN MARKET, BY CATEGORY, 2024 VS. 2029 (USD MILLION)
    • FIGURE 14 BETA-GLUCAN MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
    • FIGURE 15 BETA-GLUCAN MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
    • FIGURE 16 BETA-GLUCAN MARKET SHARE AND GROWTH RATE, BY REGION, 2024 (BY VALUE)

4 PREMIUM INSIGHTS

  • 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN BETA-GLUCAN MARKET
    • FIGURE 17 CONSUMER PREFERENCES FOR HEALTHY AND NUTRITIONAL PROTEIN TO DRIVE BETA-GLUCAN MARKET
  • 4.2 ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY AND COUNTRY
    • FIGURE 18 CHINA AND SOLUBLE SEGMENT TO ACCOUNT FOR SIGNIFICANT SHARES IN 2024
  • 4.3 BETA-GLUCAN MARKET, BY TYPE
    • FIGURE 19 (1,3 BETA-GLUCAN) SEGMENT TO ACCOUNT FOR LARGEST MARKET DURING FORECAST PERIOD
  • 4.4 BETA-GLUCAN MARKET, BY SOURCE
    • FIGURE 20 CEREALS & GRAINS SEGMENT TO LARGEST MARKET DURING FORECAST PERIOD
  • 4.5 BETA-GLUCAN MARKET, BY CATEGORY
    • FIGURE 21 SOLUBLE SEGMENT TO ACCOUNT FOR LARGER MARKET DURING FORECAST PERIOD
  • 4.6 BETA-GLUCAN MARKET, BY APPLICATION
    • FIGURE 22 FOOD & BEVERAGES SEGMENT TO ACCOUNT FOR LARGEST MARKET DURING FORECAST PERIOD
  • 4.7 BETA-GLUCAN MARKET, BY CATEGORY AND REGION
    • FIGURE 23 SOLUBLE SEGMENT TO LEAD ACROSS ALL REGIONAL MARKETS DURING FORECAST PERIOD
  • 4.8 BETA-GLUCAN MARKET: REGIONAL SNAPSHOT
    • FIGURE 24 US TO DOMINATE BETA-GLUCAN MARKET IN 2024

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MACROECONOMIC INDICATORS
    • 5.2.1 RISING GLOBAL DOMESTIC PRODUCT AND POPULATION GROWTH TO DRIVE APPETITE FOR BETA-GLUCAN
    • FIGURE 25 GLOBAL POPULATION GROWTH, 1950-2050 (BILLION)
    • FIGURE 26 GDP GROWTH, 2016-2022 (TRILLION)
    • 5.2.2 RISING HEALTH CONCERNS AND GROWTH IN DISEASES
    • FIGURE 27 PERCENTAGE POPULATION OF CANCER PATIENTS, BY REGION, 2022
    • 5.2.3 INCREASE IN CONSUMPTION OF DIETARY FIBERS
  • 5.3 MARKET DYNAMICS
    • FIGURE 28 BETA-GLUCAN MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.3.1 DRIVERS
      • 5.3.1.1 Growth in health consciousness and increasing health expenditure
    • FIGURE 29 GLOBAL OECD HEALTH SPENDING AS SHARE OF GLOBAL DOMESTIC PRODUCT, 2017-2021
      • 5.3.1.2 Increasing research and application of beta-glucan in fast-moving industries
    • 5.3.2 RESTRAINTS
      • 5.3.2.1 Inconsistency in regulatory norms governing beta-glucan
      • 5.3.2.2 Price volatility of raw materials
    • 5.3.3 OPPORTUNITIES
      • 5.3.3.1 Growing demand for natural and plant-based ingredients
      • 5.3.3.2 Demand for personalized nutrition and tailored beta-glucan products
      • 5.3.3.3 Untapped beta-glucan applications
    • 5.3.4 CHALLENGES
      • 5.3.4.1 Lack of consumer awareness regarding benefits of beta-glucan
      • 5.3.4.2 High research and development costs

6 INDUSTRY TRENDS

  • 6.1 INTRODUCTION
  • 6.2 SUPPLY CHAIN ANALYSIS
    • FIGURE 30 BETA-GLUCAN MARKET: SUPPLY CHAIN ANALYSIS
  • 6.3 VALUE CHAIN ANALYSIS
    • FIGURE 31 BETA-GLUCAN MARKET: VALUE CHAIN ANALYSIS
    • 6.3.1 RESEARCH & DEVELOPMENT
    • 6.3.2 RAW MATERIAL SOURCING
    • 6.3.3 PRODUCTION
    • 6.3.4 DISTRIBUTION
    • 6.3.5 END USERS
  • 6.4 TRADE ANALYSIS
    • 6.4.1 IMPORT SCENARIO OF YEAST
    • FIGURE 32 HS CODE 2102: IMPORT VALUE OF YEAST, BY KEY COUNTRY, 2019-2023
    • TABLE 3 HS CODE 2102: IMPORT SCENARIO OF YEAST, BY COUNTRY, 2022 (USD)
    • 6.4.2 EXPORT SCENARIO OF YEAST
    • FIGURE 33 HS CODE 2102: EXPORT VALUE OF YEAST, BY KEY COUNTRY, 2019-2023
    • TABLE 4 HS CODE 2102: EXPORT SCENARIO OF YEAST, BY COUNTRY, 2022 (USD)
    • 6.4.3 IMPORT SCENARIO OF MUSHROOMS
    • FIGURE 34 HS CODE 2003: IMPORT VALUE OF MUSHROOMS, BY KEY COUNTRY, 2019-2023
    • TABLE 5 HS CODE 2003: IMPORT SCENARIO OF MUSHROOMS, BY COUNTRY, 2022 (USD)
    • 6.4.4 EXPORT SCENARIO OF MUSHROOMS
    • FIGURE 35 HS CODE 2003: EXPORT VALUE OF MUSHROOMS, BY KEY COUNTRY, 2019-2023
    • TABLE 6 HS CODE 2003: EXPORT SCENARIO OF MUSHROOMS, BY COUNTRY, 2022 (USD)
    • 6.4.5 IMPORT SCENARIO OF OATS
    • FIGURE 36 HS CODE 1004: IMPORT VALUE OF OATS, BY KEY COUNTRY, 2019-2023
    • TABLE 7 HS CODE 1004: IMPORT SCENARIO OF OATS, BY COUNTRY, 2022 (USD)
    • 6.4.6 EXPORT SCENARIO OF OATS
    • FIGURE 37 HS CODE 1004: EXPORT VALUE OF OATS, BY KEY COUNTRY, 2019-2023
    • TABLE 8 HS CODE 1004: EXPORT SCENARIO OF OATS, BY COUNTRY, 2022 (USD)
    • 6.4.7 IMPORT SCENARIO OF BARLEY
    • FIGURE 38 HS CODE 1003: IMPORT VALUE OF BARLEY, BY KEY COUNTRY, 2019-2023
    • TABLE 9 HS CODE 1003: IMPORT SCENARIO OF BARLEY, BY COUNTRY, 2022 (USD)
    • 6.4.8 EXPORT SCENARIO OF BARLEY
    • FIGURE 39 HS CODE 1003: EXPORT VALUE OF BARLEY, BY KEY COUNTRY, 2019-2023
    • TABLE 10 HS CODE 1003: EXPORT SCENARIO OF BARLEY, BY COUNTRY, 2022 (USD)
  • 6.5 TECHNOLOGY ANALYSIS
    • 6.5.1 KEY TECHNOLOGIES
      • 6.5.1.1 Encapsulation
    • 6.5.2 COMPLEMENTARY TECHNOLOGIES
      • 6.5.2.1 High-purity yeast beta-glucan technology
    • 6.5.3 ADJACENT TECHNOLOGIES
      • 6.5.3.1 New avenues for yeast culture and extraction
  • 6.6 PRICING ANALYSIS
    • 6.6.1 AVERAGE SELLING PRICE TREND, BY REGION
    • TABLE 11 BETA-GLUCAN MARKET: AVERAGE SELLING PRICE TREND, BY REGION, 2023-2029 (USD/TONS)
    • 6.6.2 AVERAGE SELLING PRICE TREND, BY SOURCE
    • TABLE 12 BETA-GLUCAN MARKET: AVERAGE SELLING PRICE TREND, BY SOURCE, 2023-2029 (USD/TONS)
    • FIGURE 40 AVERAGE SELLING PRICE TREND, BY SOURCE (USD/TONS)
  • 6.7 ECOSYSTEM/MARKET MAP
    • 6.7.1 DEMAND SIDE
    • 6.7.2 SUPPLY SIDE
    • FIGURE 41 KEY PLAYERS IN BETA-GLUCAN MARKET ECOSYSTEM
    • TABLE 13 BETA-GLUCAN MARKET: ECOSYSTEM
  • 6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • FIGURE 42 REVENUE SHIFT FOR BETA-GLUCAN MARKET VENDORS
  • 6.9 PATENT ANALYSIS
    • TABLE 14 LIST OF MAJOR PATENTS PERTAINING TO BETA-GLUCAN MARKET, 2014-2024
    • FIGURE 43 NUMBER OF PATENTS GRANTED FOR BETA-GLUCAN, 2014-2023
    • FIGURE 44 REGIONAL ANALYSIS OF PATENTS GRANTED FOR BETA-GLUCAN
  • 6.10 KEY CONFERENCES AND EVENTS
    • TABLE 15 BETA-GLUCAN MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2024
  • 6.11 REGULATORY LANDSCAPE
    • 6.11.1 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
      • 6.11.1.1 North America
    • TABLE 16 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
      • 6.11.1.2 Europe
    • TABLE 17 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
      • 6.11.1.3 Asia Pacific
    • TABLE 18 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
      • 6.11.1.4 RoW
    • TABLE 19 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 6.11.2 REGULATORY FRAMEWORK
      • 6.11.2.1 Introduction
      • 6.11.2.2 North America
        • 6.11.2.2.1 US Food and Drug Administration (21CFR101.14)
        • 6.11.2.2.2 US Food and Drug Administration (21CFR101.81)
      • 6.11.2.3 European Food Safety Authority
        • 6.11.2.3.1 European Union
  • 6.12 PORTER'S FIVE FORCES' ANALYSIS
    • TABLE 20 PORTER'S FIVE FORCES' IMPACT ON BETA-GLUCAN MARKET
    • 6.12.1 THREAT OF NEW ENTRANTS
    • 6.12.2 THREAT OF SUBSTITUTES
    • 6.12.3 BARGAINING POWER OF SUPPLIERS
    • 6.12.4 BARGAINING POWER OF BUYERS
    • 6.12.5 INTENSITY OF COMPETITIVE RIVALRY
  • 6.13 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 6.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 45 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP APPLICATIONS
    • TABLE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP APPLICATIONS
    • 6.13.2 BUYING CRITERIA
    • TABLE 22 KEY BUYING CRITERIA FOR TOP APPLICATIONS
    • FIGURE 46 KEY BUYING CRITERIA FOR TOP APPLICATIONS
  • 6.14 CASE STUDY ANALYSIS
    • 6.14.1 CARGILL INVESTED USD 35 MILLION TO PRODUCE SOLUBLE FIBERS THAT MEET CONSUMER DEMAND FOR HEALTHY PRODUCTS
    • 6.14.2 TATE & LYLE ENTERED INTO PARTNERSHIP WITH SOLEVO TO DISTRIBUTE WIDE RANGE OF PRODUCTS AND TAP UNTAPPED OPPORTUNITIES
  • 6.15 BETA-GLUCAN PURITY ANALYSIS
    • 6.15.1 ACIDIC EXTRACTION
    • 6.15.2 ALKALINE EXTRACTION
    • 6.15.3 WATER EXTRACTION
    • 6.15.4 ENZYMATIC EXTRACTION

7 BETA-GLUCAN MARKET, BY EXTRACTION METHOD

  • 7.1 INTRODUCTION
    • TABLE 23 BETA-GLUCAN YIELDS AND PRODUCTION TECHNOLOGIES FROM VARIOUS SOURCES
  • 7.2 BETA-GLUCAN FROM CEREALS
  • 7.3 BETA-GLUCAN FROM YEAST

8 BETA-GLUCAN MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 24 APPLICATION OVERVIEW
    • FIGURE 47 BETA-GLUCAN MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
    • TABLE 25 BETA-GLUCAN MARKET: BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 26 BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • 8.2 FOOD & BEVERAGES
    • 8.2.1 INCREASING AWARENESS OF HEALTH BENEFITS IN PREVENTING AND MANAGING CHRONIC DISEASES TO DRIVE DEMAND FOR BETA-GLUCAN
    • TABLE 27 FOOD & BEVERAGES: BETA-GLUCAN MARKET, BY REGION, 2019-2023 (USD MILLION)
    • TABLE 28 FOOD & BEVERAGES: BETA-GLUCAN MARKET, BY REGION, 2024-2029 (USD MILLION)
  • 8.3 PERSONAL CARE
    • 8.3.1 GROWING CONSUMER DEMAND FOR NATURAL AND HEALTHY PRODUCTS AND AWARENESS REGARDING SKIN HEALTH TO PROPEL MARKET
    • TABLE 29 PERSONAL CARE: BETA-GLUCAN MARKET, BY REGION, 2019-2023 (USD MILLION)
    • TABLE 30 PERSONAL CARE: BETA-GLUCAN MARKET, BY REGION, 2024-2029 (USD MILLION)
      • 8.3.1.1 By form
        • 8.3.1.1.1 Creams
        • 8.3.1.1.2 Lotions
        • 8.3.1.1.3 Other personal care forms
    • TABLE 31 PERSONAL CARE: BETA-GLUCAN MARKET, BY FORM, 2019-2023 (USD MILLION)
    • TABLE 32 PERSONAL CARE: BETA-GLUCAN MARKET, BY FORM, 2024-2029 (USD MILLION)
      • 8.3.1.2 By functionality
        • 8.3.1.2.1 Spot reduction
        • 8.3.1.2.2 Skin treatment/Wound healing
        • 8.3.1.2.3 Skin moisturization & hydration
        • 8.3.1.2.4 Anti-irritation/Anti-inflammatory
        • 8.3.1.2.5 Collagen stimulation & anti-aging
        • 8.3.1.2.6 Other personal care functionalities
    • TABLE 33 PERSONAL CARE: BETA-GLUCAN MARKET, BY FUNCTIONALITY, 2019-2023 (USD MILLION)
    • TABLE 34 PERSONAL CARE: BETA-GLUCAN MARKET, BY FUNCTIONALITY, 2024-2029 (USD MILLION)
  • 8.4 COSMETICS
    • 8.4.1 BETA-GLUCAN TO IMPROVE SPREADABILITY OF FORMULATIONS AND ENHANCE THEIR ADHERENCE TO SKIN
    • TABLE 35 COSMETICS: BETA-GLUCAN MARKET, BY REGION, 2019-2023 (USD MILLION)
    • TABLE 36 COSMETICS: BETA-GLUCAN MARKET, BY REGION, 2024-2029 (USD MILLION)
      • 8.4.1.1 By form
        • 8.4.1.1.1 Creams
        • 8.4.1.1.2 Lotions
        • 8.4.1.1.3 Other cosmetics forms
    • TABLE 37 COSMETICS: BETA-GLUCAN MARKET, BY FORM, 2019-2023 (USD MILLION)
    • TABLE 38 COSMETICS: BETA-GLUCAN MARKET, BY FORM, 2024-2029 (USD MILLION)
      • 8.4.1.2 By functionality
        • 8.4.1.2.1 UV protection
        • 8.4.1.2.2 Barrier enhancement
        • 8.4.1.2.3 Skin moisturization & hydration
        • 8.4.1.2.4 Collagen stimulation & anti-aging
        • 8.4.1.2.5 Other cosmetics functionalities
    • TABLE 39 COSMETICS: BETA-GLUCAN MARKET, BY FUNCTIONALITY, 2019-2023 (USD MILLION)
    • TABLE 40 COSMETICS: BETA-GLUCAN MARKET, BY FUNCTIONALITY, 2024-2029 (USD MILLION)
  • 8.5 PHARMACEUTICALS
    • 8.5.1 GOVERNMENT INVESTMENT IN BENEFITS OF BETA-GLUCAN IN PHARMACEUTICAL APPLICATIONS TO SPUR MARKET
    • TABLE 41 PHARMACEUTICALS: BETA-GLUCAN MARKET, BY REGION, 2019-2023 (USD MILLION)
    • TABLE 42 PHARMACEUTICALS: BETA-GLUCAN MARKET, BY REGION, 2024-2029 (USD MILLION)
  • 8.6 DIETARY SUPPLEMENTS
    • 8.6.1 NEED FOR IMMUNE SYSTEM SUPPORT, CHOLESTEROL REDUCTION, AND IMPROVED GUT HEALTH TO FUEL DEMAND FOR BETA-GLUCAN
    • TABLE 43 DIETARY SUPPLEMENTS: BETA-GLUCAN MARKET, BY REGION, 2019-2023 (USD MILLION)
    • TABLE 44 DIETARY SUPPLEMENTS: BETA-GLUCAN MARKET, BY REGION, 2024-2029 (USD MILLION)
  • 8.7 ANIMAL FEED
    • 8.7.1 BETA-GLUCAN TO IMPROVE GROWTH AND FEED EFFICIENCY IN LIVESTOCK AND HELP THEM RESIST INFECTIONS AND DISEASES
    • TABLE 45 ANIMAL FEED: BETA-GLUCAN MARKET, BY REGION, 2019-2023 (USD MILLION)
    • TABLE 46 ANIMAL FEED: BETA-GLUCAN MARKET, BY REGION, 2024-2029 (USD MILLION)
    • TABLE 47 ANIMAL FEED: BETA-GLUCAN MARKET, BY SUB-APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 48 ANIMAL FEED: BETA-GLUCAN MARKET, BY SUB-APPLICATION, 2024-2029 (USD MILLION)
      • 8.7.1.1 Pets
      • 8.7.1.2 Livestock

9 BETA-GLUCAN MARKET, BY BRAND

  • 9.1 INTRODUCTION
  • 9.2 EPICOR
  • 9.3 BETAVIA
  • 9.4 M-GARD
  • 9.5 AVENACARE
  • 9.6 AB BIOTEK HUMAN NUTRITION AND HEALTH
  • 9.7 YESTIMUN
  • 9.8 BENICAROS
  • 9.9 IMMUDYNE NUTRITIONAL PUREMUNE
  • 9.10 WELLMUNE
  • 9.11 OTHER BRANDS
    • 9.11.1 OATWELL
    • 9.11.2 PROMOAT
    • 9.11.3 SANACEL
    • 9.11.4 AVENACARE
    • 9.11.5 NUTRIM

10 BETA-GLUCAN MARKET, BY CATEGORY

  • 10.1 INTRODUCTION
    • FIGURE 48 BETA-GLUCAN MARKET, BY CATEGORY, 2024 VS. 2029 (USD MILLION)
    • TABLE 49 BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
    • TABLE 50 BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
  • 10.2 SOLUBLE BETA-GLUCAN
    • 10.2.1 SOLUBLE BETA-GLUCAN TO REDUCE CHOLESTEROL LEVELS AND IMPROVE IMMUNE FUNCTION
    • TABLE 51 SOLUBLE: BETA-GLUCAN MARKET, BY REGION, 2019-2023 (USD MILLION)
    • TABLE 52 SOLUBLE: BETA-GLUCAN MARKET, BY REGION, 2024-2029 (USD MILLION)
  • 10.3 INSOLUBLE BETA-GLUCAN
    • 10.3.1 INSOLUBLE BETA-GLUCAN TO MAINTAIN HEALTHY DIGESTIVE SYSTEM BY FACILITATING SMOOTH MOVEMENT OF FOOD THROUGH DIGESTIVE TRACT
    • TABLE 53 INSOLUBLE: BETA-GLUCAN MARKET, BY REGION, 2019-2023 (USD MILLION)
    • TABLE 54 INSOLUBLE: BETA-GLUCAN MARKET, BY REGION, 2024-2029 (USD MILLION)

11 BETA-GLUCAN MARKET, BY SOURCE

  • 11.1 INTRODUCTION
    • FIGURE 49 BETA-GLUCAN MARKET, BY SOURCE, 2024 VS. 2029 (USD MILLION)
    • TABLE 55 BETA-GLUCAN MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 56 BETA-GLUCAN MARKET, BY SOURCE, 2024-2029 (USD MILLION)
    • TABLE 57 BETA-GLUCAN MARKET, BY SOURCE, 2019-2023 (TONS)
    • TABLE 58 BETA-GLUCAN MARKET, BY SOURCE, 2024-2029 (TONS)
  • 11.2 CEREALS & GRAINS
    • 11.2.1 NEED FOR REDUCING CHOLESTEROL LEVELS, IMPROVING HEART HEALTH, AND BOOSTING IMMUNE SYSTEM TO DRIVE MARKET
    • TABLE 59 CEREALS & GRAINS: BETA-GLUCAN MARKET, BY REGION, 2019-2023 (USD MILLION)
    • TABLE 60 CEREALS & GRAINS: BETA-GLUCAN MARKET, BY REGION, 2024-2029 (USD MILLION)
    • TABLE 61 CEREALS & GRAINS: BETA-GLUCAN MARKET, BY REGION, 2019-2023 (TONS)
    • TABLE 62 CEREALS & GRAINS: BETA-GLUCAN MARKET, BY REGION, 2024-2029 (TONS)
  • 11.3 MUSHROOMS
    • 11.3.1 GLUCAN FROM MUSHROOMS TO OFFER IMMUNE HEALTH BENEFITS AND IMPROVE SKIN HEALTH AND ANTI-INFLAMMATORY EFFECTS
    • TABLE 63 MUSHROOMS: BETA-GLUCAN MARKET, BY REGION, 2019-2023 (USD MILLION)
    • TABLE 64 MUSHROOMS: BETA-GLUCAN MARKET, BY REGION, 2024-2029 (USD MILLION)
    • TABLE 65 MUSHROOMS: BETA-GLUCAN MARKET, BY REGION, 2019-2023 (TONS)
    • TABLE 66 MUSHROOMS: BETA-GLUCAN MARKET, BY REGION, 2024-2029 (TONS)
  • 11.4 YEAST
    • 11.4.1 RISING PREVALENCE OF CHRONIC DISEASES, GROWING AWARENESS ABOUT HEALTH BENEFITS OF BETA-GLUCAN, AND SUPPORT OF GOVERNMENTS FOR RESEARCH AND DEVELOPMENT TO FOSTER MARKET
    • TABLE 67 YEAST: BETA-GLUCAN MARKET, BY REGION, 2019-2023 (USD MILLION)
    • TABLE 68 YEAST: BETA-GLUCAN MARKET, BY REGION, 2024-2029 (USD MILLION)
    • TABLE 69 YEAST: BETA-GLUCAN MARKET, BY REGION, 2019-2023 (TONS)
    • TABLE 70 YEAST: BETA-GLUCAN MARKET, BY REGION, 2024-2029 (TONS)
  • 11.5 SEAWEED
    • 11.5.1 SEAWEED-BASED BETA-GLUCAN TO BE USED IN COSMETIC AND PERSONAL CARE PRODUCTS FOR ITS MOISTURIZING, ANTI-INFLAMMATORY, AND ANTIOXIDANT PROPERTIES
    • TABLE 71 SEAWEED: BETA-GLUCAN MARKET, BY REGION, 2019-2023 (USD MILLION)
    • TABLE 72 SEAWEED: BETA-GLUCAN MARKET, BY REGION, 2024-2029 (USD MILLION)
    • TABLE 73 SEAWEED: BETA-GLUCAN MARKET, 2019-2023 (TONS)
    • TABLE 74 SEAWEED: BETA-GLUCAN MARKET, 2024-2029 (TONS)

12 BETA-GLUCAN MARKET, BY TYPE

  • 12.1 INTRODUCTION
    • FIGURE 50 BETA-GLUCAN MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
    • TABLE 75 BETA-GLUCAN MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 76 BETA-GLUCAN MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • 12.2 1,3 BETA-GLUCAN
    • 12.2.1 1,3 BETA-GLUCAN TO ENHANCE IMMUNE FUNCTION BY ACTIVATING VARIOUS IMMUNE CELLS AND IMPROVE SKIN HEALTH
    • TABLE 77 1,3 BETA-GLUCAN: BETA-GLUCAN MARKET, BY REGION, 2019-2023 (USD MILLION)
    • TABLE 78 1,3 BETA-GLUCAN: BETA-GLUCAN MARKET, BY REGION, 2024-2029 (USD MILLION)
  • 12.3 1,4 BETA-GLUCAN
    • 12.3.1 OAT AND BARLEY-DERIVED 1,4 BETA-GLUCAN TO LOWER CHOLESTEROL AND ENHANCE CARDIOVASCULAR HEALTH
    • TABLE 79 1,4 BETA-GLUCAN: BETA-GLUCAN MARKET, BY REGION, 2019-2023 (USD MILLION)
    • TABLE 80 1,4 BETA-GLUCAN: BETA-GLUCAN MARKET, BY REGION, 2024-2029 (USD MILLION)
  • 12.4 1,6 BETA-GLUCAN
    • 12.4.1 DEMAND FOR 1,6 BETA-GLUCAN TO RISE DUE TO ITS IMMUNE-BOOSTING AND SKIN HEALTH BENEFITS
    • TABLE 81 1,6 BETA-GLUCAN: BETA-GLUCAN MARKET, BY REGION, 2019-2023 (USD MILLION)
    • TABLE 82 1,6 BETA-GLUCAN: BETA-GLUCAN MARKET, BY REGION, 2024-2029 (USD MILLION)

13 BETA-GLUCAN MARKET, BY REGION

  • 13.1 INTRODUCTION
    • FIGURE 51 ASIA PACIFIC COUNTRIES TO WITNESS SIGNIFICANT GROWTH IN BETA-GLUCAN MARKET, 2024-2029
    • TABLE 83 BETA-GLUCAN MARKET, BY REGION, 2019-2023 (USD MILLION)
    • TABLE 84 BETA-GLUCAN MARKET, BY REGION, 2024-2029 (USD MILLION)
    • TABLE 85 BETA-GLUCAN MARKET, BY REGION, 2019-2023 (TONS)
    • TABLE 86 BETA-GLUCAN MARKET, BY REGION, 2024-2029 (TONS)
  • 13.2 NORTH AMERICA
    • FIGURE 52 NORTH AMERICA: BETA-GLUCAN MARKET SNAPSHOT
    • 13.2.1 NORTH AMERICA: RECESSION IMPACT ANALYSIS
    • FIGURE 53 NORTH AMERICA: COUNTRY-LEVEL DATA OF INFLATION, 2017-2022
    • FIGURE 54 NORTH AMERICAN BETA-GLUCAN MARKET: RECESSION IMPACT ANALYSIS
    • TABLE 87 NORTH AMERICA: BETA-GLUCAN MARKET, BY COUNTRY, 2019-2023 (USD MILLION)
    • TABLE 88 NORTH AMERICA: BETA-GLUCAN MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
    • TABLE 89 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 90 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2024-2029 (USD MILLION)
    • TABLE 91 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2019-2023 (TONS)
    • TABLE 92 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2024-2029 (TONS)
    • TABLE 93 NORTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
    • TABLE 94 NORTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
    • TABLE 95 NORTH AMERICA: BETA-GLUCAN MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 96 NORTH AMERICA: BETA-GLUCAN MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 97 NORTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 98 NORTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 99 NORTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2019-2023 (USD MILLION)
    • TABLE 100 NORTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2024-2029 (USD MILLION)
    • TABLE 101 NORTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2019-2023 (USD MILLION)
    • TABLE 102 NORTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2024-2029 (USD MILLION)
    • TABLE 103 NORTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2019-2023 (USD MILLION)
    • TABLE 104 NORTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2024-2029 (USD MILLION)
    • TABLE 105 NORTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2019-2023 (USD MILLION)
    • TABLE 106 NORTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2024-2029 (USD MILLION)
    • TABLE 107 NORTH AMERICA: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 108 NORTH AMERICA: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2024-2029 (USD MILLION)
    • 13.2.2 US
      • 13.2.2.1 Increasing number of product launches by food manufacturers to fuel demand for beta-glucan
    • TABLE 109 US: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
    • TABLE 110 US: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
    • TABLE 111 US: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 112 US: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • 13.2.3 CANADA
      • 13.2.3.1 Government approvals and rising efforts from market players to accelerate market growth
    • TABLE 113 CANADA: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
    • TABLE 114 CANADA: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
    • TABLE 115 CANADA: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 116 CANADA: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • 13.2.4 MEXICO
      • 13.2.4.1 Rise in chronic lifestyle diseases, demand for health-benefiting products, and government initiatives to promote healthy lifestyles to drive market
    • TABLE 117 MEXICO: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
    • TABLE 118 MEXICO: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
    • TABLE 119 MEXICO: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 120 MEXICO: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • 13.3 EUROPE
    • 13.3.1 EUROPE: RECESSION IMPACT ANALYSIS
    • FIGURE 55 EUROPE: COUNTRY-LEVEL DATA FOR INFLATION, 2017-2022
    • FIGURE 56 EUROPEAN BETA-GLUCAN MARKET: RECESSION IMPACT ANALYSIS
    • TABLE 121 EUROPE: BETA-GLUCAN MARKET, BY COUNTRY, 2019-2023 (USD MILLION)
    • TABLE 122 EUROPE: BETA-GLUCAN MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
    • TABLE 123 EUROPE: BETA-GLUCAN MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 124 EUROPE: BETA-GLUCAN MARKET, BY SOURCE, 2024-2029 (USD MILLION)
    • TABLE 125 EUROPE: BETA-GLUCAN MARKET, BY SOURCE, 2019-2023 (TONS)
    • TABLE 126 EUROPE: BETA-GLUCAN MARKET, BY SOURCE, 2024-2029 (TONS)
    • TABLE 127 EUROPE: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
    • TABLE 128 EUROPE: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
    • TABLE 129 EUROPE: BETA-GLUCAN MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 130 EUROPE: BETA-GLUCAN MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 131 EUROPE: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 132 EUROPE: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 133 EUROPE: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2019-2023 (USD MILLION)
    • TABLE 134 EUROPE: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2024-2029 (USD MILLION)
    • TABLE 135 EUROPE: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2019-2023 (USD MILLION)
    • TABLE 136 EUROPE: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2024-2029 (USD MILLION)
    • TABLE 137 EUROPE: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2019-2023 (USD MILLION)
    • TABLE 138 EUROPE: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2024-2029 (USD MILLION)
    • TABLE 139 EUROPE: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2019-2023 (USD MILLION)
    • TABLE 140 EUROPE: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2024-2029 (USD MILLION)
    • TABLE 141 EUROPE: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 142 EUROPE: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2024-2029 (USD MILLION)
    • 13.3.2 GERMANY
      • 13.3.2.1 Inclination toward natural and organic foods and rising prevalence of health-related problems to propel market
    • TABLE 143 GERMANY: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
    • TABLE 144 GERMANY: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
    • TABLE 145 GERMANY: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 146 GERMANY: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • 13.3.3 FRANCE
      • 13.3.3.1 Rising incidence of lifestyle diseases, growing demand for functional foods, and favorable government policies to drive market
    • TABLE 147 FRANCE: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
    • TABLE 148 FRANCE: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
    • TABLE 149 FRANCE: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 150 FRANCE: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • 13.3.4 UK
      • 13.3.4.1 Rising demand for healthier and more sustainable products and government's focus on awareness programs to promote healthy diet to drive market
    • TABLE 151 UK: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
    • TABLE 152 UK: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
    • TABLE 153 UK: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 154 UK: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • 13.3.5 ITALY
      • 13.3.5.1 Rising demand for health-enriching ingredients to prevent risk of chronic diseases to foster market growth
    • TABLE 155 ITALY: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
    • TABLE 156 ITALY: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
    • TABLE 157 ITALY: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 158 ITALY: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • 13.3.6 SPAIN
      • 13.3.6.1 Rising export opportunities and need to optimize animal health to boost demand for beta-glucan
    • TABLE 159 SPAIN: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
    • TABLE 160 SPAIN: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
    • TABLE 161 SPAIN: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 162 SPAIN: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • 13.3.7 REST OF EUROPE
    • TABLE 163 REST OF EUROPE: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
    • TABLE 164 REST OF EUROPE: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
    • TABLE 165 REST OF EUROPE: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 166 REST OF EUROPE: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • 13.4 ASIA PACIFIC
    • FIGURE 57 ASIA PACIFIC: BETA-GLUCAN MARKET SNAPSHOT
    • 13.4.1 ASIA PACIFIC: RECESSION IMPACT ANALYSIS
    • FIGURE 58 ASIA PACIFIC: KEY COUNTRY-WISE INFLATION RATES, 2017-2022
    • FIGURE 59 ASIA PACIFIC: RECESSION IMPACT ANALYSIS, 2023
    • TABLE 167 ASIA PACIFIC: BETA-GLUCAN MARKET, BY COUNTRY, 2019-2023 (USD MILLION)
    • TABLE 168 ASIA PACIFIC: BETA-GLUCAN MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
    • TABLE 169 ASIA PACIFIC: BETA-GLUCAN MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 170 ASIA PACIFIC: BETA-GLUCAN MARKET, BY SOURCE, 2024-2029 (USD MILLION)
    • TABLE 171 ASIA PACIFIC: BETA-GLUCAN MARKET, BY SOURCE, 2019-2023 (TONS)
    • TABLE 172 ASIA PACIFIC: BETA-GLUCAN MARKET, BY SOURCE, 2024-2029 (TONS)
    • TABLE 173 ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
    • TABLE 174 ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
    • TABLE 175 ASIA PACIFIC: BETA-GLUCAN MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 176 ASIA PACIFIC: BETA-GLUCAN MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 177 ASIA PACIFIC: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 178 ASIA PACIFIC: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 179 ASIA PACIFIC: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2019-2023 (USD MILLION)
    • TABLE 180 ASIA PACIFIC: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2024-2029 (USD MILLION)
    • TABLE 181 ASIA PACIFIC: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2019-2023 (USD MILLION)
    • TABLE 182 ASIA PACIFIC: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2024-2029 (USD MILLION)
    • TABLE 183 ASIA PACIFIC: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2019-2023 (USD MILLION)
    • TABLE 184 ASIA PACIFIC: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2024-2029 (USD MILLION)
    • TABLE 185 ASIA PACIFIC: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2019-2023 (USD MILLION)
    • TABLE 186 ASIA PACIFIC: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2024-2029 (USD MILLION)
    • TABLE 187 ASIA PACIFIC: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 188 ASIA PACIFIC: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2024-2029 (USD MILLION)
    • 13.4.2 CHINA
      • 13.4.2.1 Higher demand for high-quality processed foods and presence of major vendors to foster market growth
    • TABLE 189 CHINA: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
    • TABLE 190 CHINA: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
    • TABLE 191 CHINA: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 192 CHINA: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • 13.4.3 JAPAN
      • 13.4.3.1 Rise in healthcare costs and higher life expectancy due to preventive healthcare measures to drive market
    • TABLE 193 JAPAN: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
    • TABLE 194 JAPAN: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
    • TABLE 195 JAPAN: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 196 JAPAN: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • 13.4.4 INDIA
      • 13.4.4.1 Promotion of innovation and product development in food industry to fuel demand for beta-glucan
    • TABLE 197 INDIA: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
    • TABLE 198 INDIA: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
    • TABLE 199 INDIA: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 200 INDIA: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • 13.4.5 AUSTRALIA & NEW ZEALAND
      • 13.4.5.1 Need to promote animal growth, boost immunity, and improve overall productivity to propel market
    • TABLE 201 AUSTRALIA & NEW ZEALAND: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
    • TABLE 202 AUSTRALIA & NEW ZEALAND: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
    • TABLE 203 AUSTRALIA & NEW ZEALAND: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 204 AUSTRALIA & NEW ZEALAND: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • 13.4.6 REST OF ASIA PACIFIC
    • TABLE 205 REST OF ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
    • TABLE 206 REST OF ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
    • TABLE 207 REST OF ASIA PACIFIC: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 208 REST OF ASIA PACIFIC: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • 13.5 SOUTH AMERICA
    • 13.5.1 SOUTH AMERICA: RECESSION IMPACT ANALYSIS
    • FIGURE 60 SOUTH AMERICA: COUNTRY-LEVEL DATA FOR INFLATION, 2017-2022
    • FIGURE 61 SOUTH AMERICA BETA-GLUCAN MARKET: RECESSION IMPACT ANALYSIS
    • TABLE 209 SOUTH AMERICA: BETA-GLUCAN MARKET, BY COUNTRY, 2019-2023 (USD MILLION)
    • TABLE 210 SOUTH AMERICA: BETA-GLUCAN MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
    • TABLE 211 SOUTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 212 SOUTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2024-2029 (USD MILLION)
    • TABLE 213 SOUTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2019-2023 (TONS)
    • TABLE 214 SOUTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2024-2029 (TONS)
    • TABLE 215 SOUTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
    • TABLE 216 SOUTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
    • TABLE 217 SOUTH AMERICA: BETA-GLUCAN MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 218 SOUTH AMERICA: BETA-GLUCAN MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 219 SOUTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 220 SOUTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 221 SOUTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2019-2023 (USD MILLION)
    • TABLE 222 SOUTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2024-2029 (USD MILLION)
    • TABLE 223 SOUTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2019-2023 (USD MILLION)
    • TABLE 224 SOUTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2024-2029 (USD MILLION)
    • TABLE 225 SOUTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2019-2023 (USD MILLION)
    • TABLE 226 SOUTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2024-2029 (USD MILLION)
    • TABLE 227 SOUTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2019-2023 (USD MILLION)
    • TABLE 228 SOUTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2024-2029 (USD MILLION)
    • TABLE 229 SOUTH AMERICA: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 230 SOUTH AMERICA: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2024-2029 (USD MILLION)
    • 13.5.2 BRAZIL
      • 13.5.2.1 Rising geriatric population, surge in obesity levels, urbanization, and health consciousness to spur market growth
    • TABLE 231 BRAZIL: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
    • TABLE 232 BRAZIL: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
    • TABLE 233 BRAZIL: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 234 BRAZIL: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • 13.5.3 ARGENTINA
      • 13.5.3.1 Need for reducing cholesterol levels and promoting digestion to fuel demand for oats-derived beta-glucan
    • TABLE 235 ARGENTINA: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
    • TABLE 236 ARGENTINA: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
    • TABLE 237 ARGENTINA: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 238 ARGENTINA: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • 13.5.4 REST OF SOUTH AMERICA
    • TABLE 239 REST OF SOUTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
    • TABLE 240 REST OF SOUTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
    • TABLE 241 REST OF SOUTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 242 REST OF SOUTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • 13.6 REST OF THE WORLD (ROW)
    • 13.6.1 ROW: RECESSION IMPACT ANALYSIS
    • FIGURE 62 ROW: KEY COUNTRY-WISE INFLATION RATES, 2017-2022
    • FIGURE 63 ROW: RECESSION IMPACT ANALYSIS, 2023
    • TABLE 243 ROW: BETA-GLUCAN MARKET, BY COUNTRY, 2019-2023 (USD MILLION)
    • TABLE 244 ROW: BETA-GLUCAN MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
    • TABLE 245 ROW: BETA-GLUCAN MARKET, BY SOURCE, 2019-2023 (USD MILLION)
    • TABLE 246 ROW: BETA-GLUCAN MARKET, BY SOURCE, 2024-2029 (USD MILLION)
    • TABLE 247 ROW: BETA-GLUCAN MARKET, BY SOURCE, 2019-2023 (TONS)
    • TABLE 248 ROW: BETA-GLUCAN MARKET, BY SOURCE, 2024-2029 (TONS)
    • TABLE 249 ROW: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
    • TABLE 250 ROW: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
    • TABLE 251 ROW: BETA-GLUCAN MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 252 ROW: BETA-GLUCAN MARKET, BY TYPE, 2024-2029 (USD MILLION)
    • TABLE 253 ROW: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 254 ROW: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • TABLE 255 ROW: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2019-2023 (USD MILLION)
    • TABLE 256 ROW: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2024-2029 (USD MILLION)
    • TABLE 257 ROW: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2019-2023 (USD MILLION)
    • TABLE 258 ROW: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2024-2029 (USD MILLION)
    • TABLE 259 ROW: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2019-2023 (USD MILLION)
    • TABLE 260 ROW: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2024-2029 (USD MILLION)
    • TABLE 261 ROW: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2019-2023 (USD MILLION)
    • TABLE 262 ROW: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2024-2029 (USD MILLION)
    • TABLE 263 ROW: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 264 ROW: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2024-2029 (USD MILLION)
    • 13.6.2 MIDDLE EAST
      • 13.6.2.1 Expanding middle-class population and industrial growth and increased health and wellness initiatives in Middle East to drive market
    • TABLE 265 MIDDLE EAST: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
    • TABLE 266 MIDDLE EAST: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
    • TABLE 267 MIDDLE EAST: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 268 MIDDLE EAST: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
    • 13.6.3 AFRICA
      • 13.6.3.1 Growing demand for natural and functional ingredients to boost demand for beta-glucan ingredients
    • TABLE 269 AFRICA: BETA-GLUCAN MARKET, BY CATEGORY, 2019-2023 (USD MILLION)
    • TABLE 270 AFRICA: BETA-GLUCAN MARKET, BY CATEGORY, 2024-2029 (USD MILLION)
    • TABLE 271 AFRICA: BETA-GLUCAN MARKET, BY APPLICATION, 2019-2023 (USD MILLION)
    • TABLE 272 AFRICA: BETA-GLUCAN MARKET, BY APPLICATION, 2024-2029 (USD MILLION)

14 COMPETITIVE LANDSCAPE

  • 14.1 OVERVIEW
  • 14.2 REVENUE ANALYSIS
    • FIGURE 64 SEGMENTAL REVENUE ANALYSIS OF KEY PLAYERS, 2019-2023 (USD BILLION)
  • 14.3 MARKET SHARE ANALYSIS
    • TABLE 273 BETA-GLUCAN MARKET: MARKET SHARE ANALYSIS, 2023
  • 14.4 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • TABLE 274 OVERVIEW OF STRATEGIES ADOPTED BY KEY BETA-GLUCAN PLAYERS
  • 14.5 COMPANY VALUATION AND FINANCIAL METRICS
    • FIGURE 65 COMPANY VALUATION
    • FIGURE 66 EV/EBITDA OF FEW MAJOR PLAYERS
  • 14.6 BRAND/PRODUCT COMPARISON ANALYSIS
    • FIGURE 67 BETA-GLUCAN MARKET: BRAND/PRODUCT COMPARISON ANALYSIS
  • 14.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 14.7.1 STARS
    • 14.7.2 EMERGING LEADERS
    • 14.7.3 PERVASIVE PLAYERS
    • 14.7.4 PARTICIPANTS
    • FIGURE 68 BETA-GLUCAN MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2023
    • 14.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 14.7.5.1 Company footprint
    • FIGURE 69 OVERALL COMPANY FOOTPRINT
      • 14.7.5.2 Regional footprint
    • TABLE 275 REGIONAL FOOTPRINT
      • 14.7.5.3 Source footprint
    • TABLE 276 SOURCE FOOTPRINT
      • 14.7.5.4 Application footprint
    • TABLE 277 APPLICATION FOOTPRINT
      • 14.7.5.5 Type footprint
    • TABLE 278 TYPE FOOTPRINT
  • 14.8 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023
    • 14.8.1 PROGRESSIVE COMPANIES
    • 14.8.2 RESPONSIVE COMPANIES
    • 14.8.3 DYNAMIC COMPANIES
    • 14.8.4 STARTING BLOCKS
    • FIGURE 70 BETA-GLUCAN MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2023
    • 14.8.5 COMPETITIVE BENCHMARKING, START-UPS/SMES, 2023
      • 14.8.5.1 Detailed list of key start-ups/SMEs
    • TABLE 279 BETA-GLUCAN MARKET: LIST OF KEY START-UPS/SMES
      • 14.8.5.2 Competitive benchmarking of key start-ups/SMEs
    • TABLE 280 BETA-GLUCAN MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES
  • 14.9 COMPETITIVE SCENARIO AND TRENDS
    • 14.9.1 DEALS
    • TABLE 281 BETA-GLUCAN MARKET: DEALS, 2020-2022
    • 14.9.2 EXPANSIONS
    • TABLE 282 BETA-GLUCAN MARKET: EXPANSIONS, 2019-2022

15 COMPANY PROFILES

  • (Business Overview, Products/Solutions Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
  • 15.1 KEY PLAYERS
    • 15.1.1 TATE & LYLE PLC
    • TABLE 283 TATE & LYLE PLC: BUSINESS OVERVIEW
    • FIGURE 71 TATE & LYLE PLC: COMPANY SNAPSHOT
    • TABLE 284 TATE & LYLE PLC: INGREDIENTS OFFERED
    • TABLE 285 TATE & LYLE PLC: DEALS
    • TABLE 286 TATE & LYLE PLC: EXPANSIONS
    • TABLE 287 TATE & LYLE PLC: OTHER DEVELOPMENTS
    • 15.1.2 KERRY GROUP PLC
    • TABLE 288 KERRY GROUP PLC: BUSINESS OVERVIEW
    • FIGURE 72 KERRY GROUP PLC: COMPANY SNAPSHOT
    • TABLE 289 KERRY GROUP PLC: INGREDIENTS OFFERED
    • 15.1.3 DSM-FIRMENICH
    • TABLE 290 DSM-FIRMENICH: BUSINESS OVERVIEW
    • FIGURE 73 DSM-FIRMENICH: COMPANY SNAPSHOT
    • TABLE 291 DSM-FIRMENICH: INGREDIENTS OFFERED
    • TABLE 292 DSM-FIRMENICH: EXPANSIONS
    • 15.1.4 ANGEL YEAST CO., LTD.
    • TABLE 293 ANGEL YEAST CO., LTD.: BUSINESS OVERVIEW
    • FIGURE 74 ANGEL YEAST CO., LTD: COMPANY SNAPSHOT
    • TABLE 294 ANGEL YEAST CO., LTD.: INGREDIENTS OFFERED
    • TABLE 295 ANGEL YEAST CO., LTD.: PRODUCTS OFFERED
    • TABLE 296 ANGEL YEAST CO., LTD.: EXPANSIONS
    • 15.1.5 MERCK
    • TABLE 297 MERCK: BUSINESS OVERVIEW
    • FIGURE 75 MERCK: COMPANY SNAPSHOT
    • TABLE 298 MERCK: INGREDIENTS OFFERED
    • TABLE 299 MERCK: EXPANSIONS
    • 15.1.6 ASSOCIATED BRITISH FOODS PLC
    • TABLE 300 ASSOCIATED BRITISH FOODS PLC: BUSINESS OVERVIEW
    • FIGURE 76 ASSOCIATED BRITISH FOODS PLC: COMPANY SNAPSHOT
    • TABLE 301 ASSOCIATED BRITISH FOODS PLC: INGREDIENTS OFFERED
    • TABLE 302 ASSOCIATED BRITISH FOODS PLC: PRODUCTS OFFERED
    • 15.1.7 CEAPRO INC.
    • TABLE 303 CEAPRO INC.: BUSINESS OVERVIEW
    • FIGURE 77 CEAPRO INC.: COMPANY SNAPSHOT
    • TABLE 304 CEAPRO INC.: INGREDIENTS OFFERED
    • TABLE 305 CEAPRO INC.: DEALS
    • TABLE 306 CEAPRO INC.: OTHER DEVELOPMENTS
    • 15.1.8 LESAFFRE
    • TABLE 307 LESAFFRE: BUSINESS OVERVIEW
    • TABLE 308 LESAFFRE: INGREDIENTS OFFERED
    • TABLE 309 LESAFFRE: PRODUCTS OFFERED
    • TABLE 310 LESAFFRE: DEALS
    • 15.1.9 KEMIN INDUSTRIES, INC.
    • TABLE 311 KEMIN INDUSTRIES, INC.: BUSINESS OVERVIEW
    • TABLE 312 KEMIN INDUSTRIES, INC.: INGREDIENTS OFFERED
    • TABLE 313 KEMIN INDUSTRIES, INC.: EXPANSIONS
    • TABLE 314 KEMIN INDUSTRIES, INC.: OTHER DEVELOPMENTS
    • 15.1.10 FOODCHEM INTERNATIONAL CORPORATION
    • TABLE 315 FOODCHEM INTERNATIONAL CORPORATION: BUSINESS OVERVIEW
    • TABLE 316 FOODCHEM INTERNATIONAL CORPORATION: INGREDIENTS OFFERED
    • 15.1.11 LALLEMAND
    • TABLE 317 LALLEMAND: BUSINESS OVERVIEW
    • TABLE 318 LALLEMAND: INGREDIENTS OFFERED
    • TABLE 319 LALLEMAND: PRODUCTS OFFERED
    • TABLE 320 LALLEMAND: DEALS
    • 15.1.12 BIORIGIN
    • TABLE 321 BIORIGIN: BUSINESS OVERVIEW
    • TABLE 322 BIORIGIN: INGREDIENTS OFFERED
    • 15.1.13 NUTRISCIENCE INNOVATIONS, LLC
    • TABLE 323 NUTRISCIENCE INNOVATIONS, LLC: BUSINESS OVERVIEW
    • TABLE 324 NUTRISCIENCE INNOVATIONS, LLC: INGREDIENTS OFFERED
    • 15.1.14 LEIBER
    • TABLE 325 LEIBER: BUSINESS OVERVIEW
    • TABLE 326 LEIBER: INGREDIENTS OFFERED
    • TABLE 327 LEIBER: PRODUCTS OFFERED
    • 15.1.15 GARUDA INTERNATIONAL INC.
    • TABLE 328 GARUDA INTERNATIONAL INC.: BUSINESS OVERVIEW
    • TABLE 329 GARUDA INTERNATIONAL INC.: INGREDIENTS OFFERED
  • 15.2 OTHER PLAYERS
    • 15.2.1 VW-INGREDIENTS
    • TABLE 330 VW-INGREDIENTS: BUSINESS OVERVIEW
    • TABLE 331 VW-INGREDIENTS: INGREDIENTS OFFERED
    • 15.2.2 SUPER BETA GLUCAN
    • TABLE 332 SUPER BETA GLUCAN: BUSINESS OVERVIEW
    • TABLE 333 SUPER BETA GLUCAN: INGREDIENTS OFFERED
    • 15.2.3 GLYCANOVA AS
    • TABLE 334 GLYCANOVA AS: BUSINESS OVERVIEW
    • TABLE 335 GLYCANOVA AS: INGREDIENTS OFFERED
    • TABLE 336 GLYCANOVA AS: PRODUCTS OFFERED
    • 15.2.4 SPECIALTY BIOTECH CO., LTD.
    • TABLE 337 SPECIALTY BIOTECH CO., LTD.: BUSINESS OVERVIEW
    • TABLE 338 SPECIALTY BIOTECH CO., LTD.: INGREDIENTS OFFERED
    • 15.2.5 ALGALIF ICELAND HF.
    • TABLE 339 ALGALIF ICELAND HF.: BUSINESS OVERVIEW
    • TABLE 340 ALGALIF ICELAND HF.: INGREDIENTS OFFERED
    • 15.2.6 NATURAL BIOLOGICS
    • TABLE 341 NATURAL BIOLOGICS: BUSINESS OVERVIEW
    • 15.2.7 ABAC R&D AG
    • TABLE 342 ABAC R&D AG: BUSINESS OVERVIEW
    • 15.2.8 BENEO
    • TABLE 343 BENEO: BUSINESS OVERVIEW
    • 15.2.9 L&P FOOD INGREDIENT CO., LTD
    • TABLE 344 L&P FOOD INGREDIENT CO., LTD: BUSINESS OVERVIEW
    • 15.2.10 BETA BIO TECHNOLOGY SP. Z O. O.
    • TABLE 345 BETA BIO TECHNOLOGY SP. Z O. O. : BUSINESS OVERVIEW
  • 15.3 PRODUCT-BASED COMPANIES
    • 15.3.1 CARGILL, INCORPORATED
    • TABLE 346 CARGILL, INCORPORATED: BUSINESS OVERVIEW
    • 15.3.2 INTERNATIONAL FLAVORS & FRAGRANCES, INC.
    • TABLE 347 INTERNATIONAL FLAVORS & FRAGRANCES, INC.: BUSINESS OVERVIEW
    • 15.3.3 VIVESA HOLDING S.R.O
    • TABLE 348 VIVESA HOLDING S.R.O: BUSINESS OVERVIEW
    • 15.3.4 ALERIS
    • TABLE 349 ALERIS: BUSINESS OVERVIEW
    • 15.3.5 ICC
    • TABLE 350 ICC: BUSINESS OVERVIEW
    • 15.3.6 PROSOL S.P.A.
    • TABLE 351 PROSOL S.P.A.: BUSINESS OVERVIEW
    • 15.3.7 ABN APLICACIONES BIOLOGICAS A LA NUTRICION
    • TABLE 352 ABN APLICACIONES BIOLOGICAS A LA NUTRICION: BUSINESS OVERVIEW
    • 15.3.8 EW NUTRITION
    • TABLE 353 EW NUTRITION: BUSINESS OVERVIEW
    • 15.3.9 BIOCHEM ZUSATZSTOFFE HANDELS- UND PRODUKTIONSGESELLSCHAFT MBH
    • TABLE 354 BIOCHEM ZUSATZSTOFFE HANDELS- UND PRODUKTIONSGESELLSCHAFT MBH: BUSINESS OVERVIEW
    • 15.3.10 MIBELLE BIOCHEMISTRY
    • TABLE 355 MIBELLE BIOCHEMISTRY: BUSINESS OVERVIEW
  • *Details on Business Overview, Products/Solutions Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

16 ADJACENT & RELATED MARKETS

  • 16.1 INTRODUCTION
    • TABLE 356 ADJACENT MARKETS
  • 16.2 STUDY LIMITATIONS
  • 16.3 YEAST MARKET
    • 16.3.1 MARKET DEFINITION
    • 16.3.2 MARKET OVERVIEW
    • TABLE 357 YEAST MARKET, BY TYPE, 2019-2023 (USD MILLION)
    • TABLE 358 YEAST MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • 16.4 STARTER CULTURE MARKET
    • 16.4.1 MARKET DEFINITION
    • 16.4.2 MARKET OVERVIEW
    • TABLE 359 STARTER CULTURE MARKET, BY APPLICATION, 2017-2021 (USD MILLION)
    • TABLE 360 STARTER CULTURE MARKET, BY APPLICATION, 2022-2027 (USD MILLION)

17 APPENDIX

  • 17.1 DISCUSSION GUIDE
  • 17.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 17.3 CUSTOMIZATION OPTIONS
  • 17.4 RELATED REPORTS
  • 17.5 AUTHOR DETAILS